Clinical Trial Update: Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating octreotide acetate in microspheres for diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Octreotide acetate in microspheres (octreotide acetate)

Snippet

Sponsor: Novartis | Conditions: Diabetic Retinopathy | Phase 3 | Status: COMPLETED